No profile data available.
Telesis Bio, Inc. (TBIO) is a healthcare company in the biological analysis equipment industry, based in San Diego, United States, with about 39 full-time employees.
It reported revenue of $27.51 million for fiscal year 2023, up 0.3% from fiscal year 2022, and net income of -$49.02 million. In Q2 2024 (the quarter ended June 30, 2024) revenue was $1.55 million, down 77.9% from a year before. Its market capitalization was $19,534 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2023; market data as of October 8, 2026.
, a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide.
Telesis Bio reported $27.51 million in revenue for fiscal year 2023, up 0.3% from $27.44 million in fiscal year 2022. In Q2 2024 revenue was $1.55 million.
$19,534 as of October 8, 2026.
Listed companies of a similar size in the same industry (biological analysis equipment) include iSpecimen Inc. (ISPC), International Stem Cell Corporation (ISCO), InVitro International, Inc. (IVRO).